Integral Health Asset Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-26,000
| Closed | -$164K | – | 72 |
|
|
2022
Q4 | $164K | Buy |
26,000
+2,437
| +10% | +$15.4K | 0.03% | 59 |
|
|
2022
Q3 | $532K | Buy |
23,563
+3,046
| +15% | +$68.8K | 0.1% | 63 |
|
|
2022
Q2 | $394K | Buy |
20,517
+7,954
| +63% | +$153K | 0.08% | 64 |
|
|
2022
Q1 | $583K | Buy |
12,563
+6,938
| +123% | +$322K | 0.15% | 68 |
|
|
2021
Q4 | $399K | Hold |
5,625
| – | – | 0.11% | 68 |
|
|
2021
Q3 | $655K | Buy |
5,625
+937
| +20% | +$109K | 0.19% | 67 |
|
|
2021
Q2 | $734K | Buy |
4,688
+625
| +15% | +$97.9K | 0.2% | 67 |
|
|
2021
Q1 | $770K | Buy |
+4,063
| New | +$770K | 0.22% | 64 |
|